US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 4.250
- -0.100-2.30%
Close Jul 19 16:00 ET
1.13BMarket Cap-3512P/E (TTM)
4.360High4.200Low892.00KVolume4.330Open4.350Pre Close3.81MTurnover0.68%Turnover RatioLossP/E (Static)266.04MShares7.45052wk High1.94P/B559.69MFloat Cap2.01052wk Low--Dividend TTM131.69MShs Float53.240Historical High--Div YieldTTM3.68%Amplitude1.600Historical Low4.272Avg Price1Lot Size
Autolus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 681.04%10.09M | -72.59%1.7M | 0 | -82.86%406K | 0 | 1.29M | 311.02%6.19M | 3.83M | 2.37M | 0 |
| Operating revenue | 681.04%10.09M | -72.59%1.7M | --0 | -82.86%406K | --0 | --1.29M | 311.02%6.19M | --3.83M | --2.37M | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 33.20%48.85M | 18.87%177.23M | 173.30%40.89M | 4.33%47.85M | 2.98%47.86M | -12.23%36.67M | 5.08%149.09M | -35.23%14.96M | 13.65%45.86M | 18.48%46.48M |
| Selling and administrative expenses | 95.79%18.18M | 46.54%46.75M | 112.20%15.73M | 28.92%10.61M | 34.50%11.12M | 16.24%9.28M | 0.11%31.9M | -2.36%7.41M | -0.82%8.23M | 14.26%8.27M |
| -General and administrative expense | 95.79%18.18M | 46.54%46.75M | 112.20%15.73M | 28.92%10.61M | 34.50%11.12M | 16.24%9.28M | 0.11%31.9M | -2.36%7.41M | -0.82%8.23M | 14.26%8.27M |
| Research and development costs | 11.99%30.67M | 11.19%130.48M | 233.31%25.16M | -1.05%37.24M | -3.85%36.74M | -19.36%27.39M | 5.88%117.35M | -51.88%7.55M | 16.54%37.63M | 18.93%38.21M |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | 79.83%-166K | --0 | ---- | ---- |
| Operating profit | -9.54%-38.76M | -22.84%-175.53M | -267.18%-40.89M | -9.08%-47.44M | -2.98%-47.86M | 15.33%-35.38M | -1.79%-142.89M | 51.79%-11.14M | -7.78%-43.49M | -23.22%-46.48M |
| Net non-operating interest income expense | -745.51%-12.34M | -338.54%-31.56M | -1,235.20%-27.12M | 18.81%-1.37M | 6.04%-1.62M | 17.20%-1.46M | -753.74%-7.2M | -112.45%-2.03M | -6,117.86%-1.69M | -4,197.62%-1.72M |
| Non-operating interest income | 101.19%6.93M | 690.69%13.51M | 111.08%3.01M | 2,109.70%3.65M | 3,723.60%3.4M | 12,207.14%3.45M | 551.91%1.71M | 857.05%1.43M | 489.29%165K | 111.90%89K |
| Non-operating interest expense | 292.84%19.27M | 406.09%45.07M | 771.51%30.13M | 171.03%5.01M | 177.35%5.02M | 174.02%4.91M | 705.88%8.91M | 212.85%3.46M | --1.85M | --1.81M |
| Other net income (expense) | 46.25%-1.61M | -186.15%-1.31M | -44.33%3.19M | 47.09%-1.98M | 134.49%459K | -447.21%-2.99M | 285.51%1.52M | 6,474.44%5.74M | -493.27%-3.74M | 28.02%-1.33M |
| Special income (charges) | --0 | -710.29%-4.17M | --0 | ---382K | ---23K | ---3.77M | 23.82%-515K | -12,775.00%-515K | --0 | --0 |
| -Less:Impairment of capital assets | ---- | --382K | --0 | --382K | ---- | ---- | --0 | --0 | --0 | ---- |
| -Gain on sale of property,plant,equipment | --0 | -636.12%-3.79M | --0 | --0 | ---23K | ---3.77M | 23.82%-515K | -12,775.00%-515K | --0 | --0 |
| Other non- operating income (expenses) | -305.24%-1.61M | 40.38%2.86M | -48.91%3.19M | 57.30%-1.6M | 136.21%482K | -9.07%782K | 1,505.52%2.04M | 7,369.77%6.25M | -493.27%-3.74M | 28.02%-1.33M |
| Income before tax | -32.32%-52.7M | -40.27%-208.4M | -772.39%-64.81M | -3.82%-50.79M | 1.03%-49.02M | 6.70%-39.83M | -4.60%-148.57M | 69.23%-7.43M | -24.24%-48.92M | -25.30%-49.53M |
| Income tax | 42.86%-8K | -106.99%-19K | -36.68%12.36M | 19.70%-4.94M | 53.57%-3.47M | 99.75%-14K | 368.97%272K | 11.40%19.52M | -14.24%-6.15M | -17.57%-7.47M |
| Net income | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M | -25.82%-42.77M | -26.79%-42.06M |
| Net income continuous Operations | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M | -25.82%-42.77M | -26.79%-42.06M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M | -25.82%-42.77M | -26.79%-42.06M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.21%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M | -25.82%-42.77M | -26.79%-42.06M |
| Basic earnings per share | -4.35%-0.24 | 23.57%-1.2 | -95.65%-0.45 | 44.68%-0.26 | 43.48%-0.26 | 43.90%-0.23 | 20.30%-1.57 | 54.90%-0.23 | 0.00%-0.47 | 2.13%-0.46 |
| Diluted earnings per share | -4.35%-0.24 | 23.57%-1.2 | -95.65%-0.45 | 44.68%-0.26 | 43.48%-0.26 | 43.90%-0.23 | 20.30%-1.57 | 54.90%-0.23 | 0.00%-0.47 | 2.13%-0.46 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg